us earns threshold pharmaceuticals 110609
On the homepage
NewsBreak
Out There
Sunday's paper
Reusse's Turkey
Threshold Pharmaceuticals' 3rd-quarter loss widens on boost in costs, expenses
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
REDWOOD CITY, Calif. - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.
The company lost $6.2 million, or 40 cents per share, compared with a loss of $4.6 million, or 49 cents per share, during the year-ago period.
Threshold reported no revenue, compared with $362,000 a year prior.
Operating expenses rose 4 percent to $5.2 million as the company continued developing its potential cancer treatment TH-302. Meanwhile, interest expense surged to $957,000 from $13,000.
Recent Business stories
Credit Suisse to buy back $79 million in auction rate securities from Colorado investors - November 6, 2009
Credit Suisse to buy back $79 million in auction rate securities from Colorado investors - Credit Suisse Securities (USA) LLC has agreed to buy back $79 million of auction rate securities from Colorado investors who struggled to sell them after the market for them froze. More
- 2 charged with running $190M Ponzi scheme
- Toyota replacing some 4M gas pedals that could jam
- FDA says Cheerios health claims lack evidence
- Minnesota's banks are bruised, but healing
- No verdict; Petters jury to resume deliberations Monday
- Jobless claims dip, spending up in sign of rebound
- Social animal
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments